IL151564A0 - Potassium channel proteins - Google Patents

Potassium channel proteins

Info

Publication number
IL151564A0
IL151564A0 IL15156401A IL15156401A IL151564A0 IL 151564 A0 IL151564 A0 IL 151564A0 IL 15156401 A IL15156401 A IL 15156401A IL 15156401 A IL15156401 A IL 15156401A IL 151564 A0 IL151564 A0 IL 151564A0
Authority
IL
Israel
Prior art keywords
kcnb
potassium channel
activity
channel proteins
modulate
Prior art date
Application number
IL15156401A
Other languages
English (en)
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Publication of IL151564A0 publication Critical patent/IL151564A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
IL15156401A 2000-03-03 2001-03-02 Potassium channel proteins IL151564A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18691500P 2000-03-03 2000-03-03
PCT/US2001/006801 WO2001066741A2 (en) 2000-03-03 2001-03-02 Kcnb: a novel potassium channel protein

Publications (1)

Publication Number Publication Date
IL151564A0 true IL151564A0 (en) 2003-04-10

Family

ID=22686808

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15156401A IL151564A0 (en) 2000-03-03 2001-03-02 Potassium channel proteins
IL151564A IL151564A (en) 2000-03-03 2002-09-02 Potassium channel proteins

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151564A IL151564A (en) 2000-03-03 2002-09-02 Potassium channel proteins

Country Status (12)

Country Link
US (2) US7462465B2 (enExample)
EP (1) EP1266003B1 (enExample)
JP (2) JP2004500825A (enExample)
CN (1) CN1426468A (enExample)
AT (1) ATE538201T1 (enExample)
AU (2) AU2001250794B2 (enExample)
CA (1) CA2401906C (enExample)
ES (1) ES2378417T3 (enExample)
IL (2) IL151564A0 (enExample)
NZ (1) NZ521205A (enExample)
WO (1) WO2001066741A2 (enExample)
ZA (1) ZA200206999B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057846A2 (en) * 2001-12-31 2003-07-17 Algos Therapeutics, Inc. Methods and materials for modulating task-3
WO2005052586A2 (en) * 2003-11-27 2005-06-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3)
WO2005075510A1 (en) * 2004-02-04 2005-08-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 9 (kcnk9)
US12416024B2 (en) 2018-03-29 2025-09-16 Transworld Technologies Inc. Biologically enhanced oil recovery methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744730B1 (fr) 1996-02-08 1998-04-17 Centre Nat Rech Scient Nouvelle famille de canaux potassium de mammifere, leur clonage et leur utilisation notamment pour le criblage de drogues
EP1051485A1 (en) 1998-01-27 2000-11-15 Smithkline Beecham Plc Trek-1 like two pore potassium channel
EP1090118A2 (en) * 1998-06-26 2001-04-11 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
DE69938667D1 (de) 1998-11-09 2008-06-19 Centre Nat Rech Scient Neue familie von säugetier-kaliumkanälen, ihre klonierung und ihre verwendung, besonders für das drogenscreening
WO2000053628A2 (en) * 1999-03-05 2000-09-14 Smithkline Beecham Plc Genes encoding human potassium channel proteins
US20020137202A1 (en) * 1999-12-21 2002-09-26 Catherine Burgess Novel proteins and nucleic acids encoding same
GB2373500B (en) 2000-02-04 2004-12-15 Aeomica Inc Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
EP1381626A2 (en) 2000-04-06 2004-01-21 Incyte Genomics, Inc. Human transporters and ion channels
AU2001294724A1 (en) 2000-09-25 2002-04-08 Millennium Pharmaceuticals, Inc. 56115, a novel human twik potassium channel and uses therefor

Also Published As

Publication number Publication date
US7462465B2 (en) 2008-12-09
CA2401906A1 (en) 2001-09-13
JP2011115169A (ja) 2011-06-16
ES2378417T3 (es) 2012-04-12
CN1426468A (zh) 2003-06-25
US20080234470A1 (en) 2008-09-25
ZA200206999B (en) 2004-05-31
ATE538201T1 (de) 2012-01-15
NZ521205A (en) 2005-09-30
AU5079401A (en) 2001-09-17
IL151564A (en) 2008-11-03
WO2001066741A9 (en) 2003-03-06
WO2001066741A2 (en) 2001-09-13
WO2001066741A3 (en) 2002-04-04
JP2004500825A (ja) 2004-01-15
EP1266003B1 (en) 2011-12-21
CA2401906C (en) 2011-07-19
AU2001250794B2 (en) 2006-03-02
EP1266003A2 (en) 2002-12-18
US20020102676A1 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
AU2085502A (en) Diagnosis and treatment of disease
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
AU4981101A (en) Subtilisin variants
WO2003022028A3 (en) Methods, reagents, kits and apparatus for protein function analysis
EP1266025A4 (en) INTERNAL PROTEIN SCAFFOLDS FOR IMITATION OF ANTIBODIES AND OTHER BINDING PROTEINS
SE0003286D0 (sv) Method and kit for human identification
DE60322880D1 (de) Einfache katalytische dna-biosensoren für ionen auf grundlage von farbveränderungen
DK0981630T3 (da) Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
ATE325203T1 (de) Nachweis und identifikation von bakteriengruppen
BRPI0001536B8 (enExample)
ATE439441T1 (de) Veränderte, fluoreszierende proteine
IL179441A0 (en) Hif prolyl hydroxylase activity assay
TR200200667T2 (tr) Leu-hirudinin E.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları.
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
WO1999000407A3 (en) Improved bacillus thuringiensis toxin
IL151564A0 (en) Potassium channel proteins
ATE288589T1 (de) Verfahren zur analyse von proteinen
ATE316577T1 (de) Das goodpasture-antigen bindende protein
DE69734586D1 (de) Retinoid-metabolisierendes protein
Li et al. Possible release of an ArgGlyArgProGln pentapeptide with innate immunity properties from acidic proline-rich proteins by proteolytic activity in commensal Streptococcus and Actinomyces species
WO2004070012A3 (en) Cell-killing molecules and methods of use thereof
WO2001079272A3 (en) Sitosterolemia susceptibility gene (ssg): compositions and methods of use
WO2001031009A3 (en) Chandra: a th1-specific gene